Opus Point Partners’ AUM, History and Investments

2. Bristol-Myers Squibb Co (NYSE:BMY)

In Bristol-Myers Squibb Co (NYSE:BMY), Opus Point owns 90,000 shares worth $5.02 million as of the end of the second quarter, also unchanged from the end of March. Billionaire Jim Simons’ Renaissance Technologies more than doubled its position in Bristol-Myers Squibb Co (NYSE:BMY) to 13.49 million shares during the second quarter.

Since the beginning of the year, Bristol-Myers Squibb Co (NYSE:BMY)’s stock has inched up by 0.30% amid an 18% drop registered in the second half of January, following the company’s announcement that it would not pursue accelerated approval of Opdivo and Yervoy combination for treatment of lung cancer. Earlier this month, the company announced mixed results for the same combination of drugs for the treatment of kidney cancer.